Phase II SBIR Grant
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
---|---|---|---|---|
Sep 20, 2022
Eko
|
Grant | $2.70M | Artificial Intelligence | Yes |
Sep 1, 2022
Matregenix
|
Grant | — | Biotechnology | — |
Grant | $3.25M | Education | Yes | |
Jun 23, 2022
Eliaz Therapeutics
|
Grant | $1.70M | Biotechnology | Yes |
Jun 15, 2022
Reliant Glycosciences
|
Grant | $1.20M | Biotechnology | Yes |
National Institutes of Health (NIH) has had 3 exits. National Institutes of Health (NIH) most notable exits include Diffinity Genomics , Trevena
Date | Company Name | Exit Type | Industry | |
---|---|---|---|---|
Aug 3, 2015 | Diffinity Genomics | M&A | Biotechnology | Detail |
Jan 31, 2014 | Trevena | IPO | Biopharma | Detail |
Nov 25, 1988 | Thermogenesis | IPO | Biotechnology | Detail |